Vistagen Therapeutics, Inc. VTGN
Set alert
0.17 USD 0.00 -0.48%
At close
0.17 0.00 0.00%
Pre-market · Nov 3, 4:00 AM ET
0.1661 Day range 0.172
0.1661 52-week range 5.14
- YTD
- -74.62%
- 1 year
- -95.75%
- Open
- 0.169
- Prev close
- 0.1683
- Mkt cap
- 7.43M
- Vol
- 842.62K
- Avg vol
- 12.32M
- EPS
- -1.66
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1661
- High
- 0.172
- Forward P/E
- -1.49
- Beta
- 0.00
- Short ratio
- 1.69
- Inst. own
- 53.63%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2025
- 50-d avg
- 2.81
- 200-d avg
- 3.60
- 1y target
- 13.00
5D chart
Signals (110)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 4:00 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 3:35 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 3:35 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 3:15 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 14 hours ago |
| MACD: Sell Signal | Nov 2, 2:00 PM | 14 hours ago |
| SMA: Bullish | Nov 2, 1:40 PM | 14 hours ago |
| SMA: Bullish | Nov 2, 1:40 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 1:30 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 1:30 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 12:30 PM | 15 hours ago |
| SMA: Bearish | Nov 2, 12:30 PM | 15 hours ago |
| SMA: Bullish | Nov 2, 12:20 PM | 16 hours ago |
Newest 20 of 110.
Analyst view
Consensus: none
Price target (mean) 13.00 +7661.2% upside
Now 0.1675
- Target (low)
- 12.00
- Target (mean)
- 13.00
- Target (high)
- 15.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.52 | -0.54 – -0.50 | -0.22 | -136.4% | 179.25K | -56.4% | 2 |
| Next quarter | -0.525 | -0.60 – -0.45 | -0.25 | -110.0% | 179.25K | -9.2% | 2 |
| Current year | -1.82 | -1.87 – -1.77 | -1.52 | -19.7% | 642.00K | -39.7% | 2 |
| Next year | -1.48 | -1.53 – -1.43 | -1.82 | +18.7% | 316.25K | -50.7% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 7, 2023 | Jefferies | Upgrade | Hold | Buy |
| Nov 14, 2023 | Stifel | Initiated | — | Buy |
| Sep 5, 2023 | Maxim Group | Maintained | Buy | Buy |
| Aug 7, 2023 | Maxim Group | Upgrade | Hold | Buy |